Novel steroid 5.alpha.-reductase inhibitors
US4317817A · kind A · utility
45Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 1980 |
| Grant date | Mar 2, 1982 |
| Priority date | — |
| Expiry date | Dec 15, 2000 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J51/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the following general formula are testosterone 5.alpha.-reductase inhibitors rendering the compounds useful in the treatment of acne and oily skin and benign prostatic hypertrophy: ##STR1## wherein R is: .dbd.O, --OH, --OCO--alkyl C.sub.1-5, --COOH, --CH.sub.2 OH, --COO--alkyl C.sub.1-6, --COCH.sub.3, ##STR2##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.